MIR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Mirion Technologies Inc (MIR) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The technical indicators are neutral to bearish, options sentiment is mixed, and there are no recent positive news catalysts. While the company shows revenue and net income growth, the EPS decline and insider selling are concerning. Analyst ratings are generally positive but have been revised downward recently. Given the lack of strong buy signals and the investor's preference for long-term growth, holding off for now is recommended.
The technical indicators for MIR are neutral to bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 51.462, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 21.521, with resistance at 22.434 and support at 20.608.
The company's Nuclear segment outlook remains strong, and the Medical segment has shown strong margins. Revenue and net income have grown YoY, and analysts generally maintain a Buy or Outperform rating.
EPS has declined by 14.29% YoY. Insider selling has increased significantly (1999.77% over the last month). Analyst price targets have been revised downward recently, and the stock's premium valuation may limit upside potential. No recent news or congress trading data is available to support a positive sentiment shift.
In 2025/Q4, Mirion reported a 9.08% YoY increase in revenue to $277.4M and a 15.33% YoY increase in net income to $17.3M. However, EPS dropped by 14.29% YoY to 0.06. Gross margin improved slightly to 48.85%, up 1.58% YoY.
Analysts have generally maintained a positive outlook with Buy or Outperform ratings, but price targets have been revised downward to $29 from higher levels. The Nuclear segment remains a key growth driver, but concerns about weaker organic growth and a backloaded 2H26 guide have been noted.
